Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

VLDLR

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Very low density lipoprotein receptor (VLDLR) is a type I transmembrane receptor in the LDL receptor family, encoded by the VLDLR gene on chromosome 9p24.2. The gene spans roughly 40 kb and contains 19 exons. Its mature protein comprises 846 amino acids, preceded by a 27-residue signal peptide. VLDLR shares the same five-domain architecture as LDLR: an N-terminal ligand-binding domain with eight cysteine-rich LA repeats; an EGF precursor-homologous region containing three EGF-like repeats and a YWTD β-propeller that drives acid-dependent ligand release; an O-linked sugar domain; a single transmembrane segment; and a 54-amino-acid cytoplasmic tail with an NPXY motif for clathrin-coated pit clustering. Alternative splicing of exons 4 and 16 yields several transcript variants, including neuronal isoforms that skip exon 4. Expression is highest in heart, skeletal muscle, adipose tissue, and brain, and is essentially absent from liver.

VLDLR acts in both lipoprotein metabolism and intracellular signaling. It binds and internalizes triacylglycerol-rich ApoE-containing lipoproteins, including VLDL, thereby helping deliver VLDL-triglyceride-derived fatty acids to peripheral tissues. Beyond its endocytic function, VLDLR serves as a receptor for Reelin, an extracellular matrix protein that controls neuronal positioning during brain development. Reelin binds directly to the first LA repeat of VLDLR in a calcium-dependent manner, inducing receptor clustering and tyrosine phosphorylation of the intracellular adaptor protein Disabled-1 (Dab1). Phosphorylated Dab1 then recruits downstream SH2 domain-containing proteins including Crk, Nckβ, and PI3K, activating signaling cascades that regulate neuronal migration and synaptic plasticity. VLDLR also undergoes regulated proteolytic processing, with α-secretase and γ-secretase releasing soluble extracellular and intracellular domains. Biallelic loss-of-function variants in VLDLR cause cerebellar hypoplasia, impaired intellectual development, and dysequilibrium syndrome 1 (CAMRQ1), characterized by non-progressive cerebellar ataxia and moderate-to-profound intellectual disability. These properties make VLDLR an important research target for studies of Reelin signaling, neuronal migration, lipoprotein metabolism, and the molecular basis of VLDLR-associated neurodevelopmental disorders.

Fig. 1 Domains organization of the LDLR superfamily members. (OA Literature)Fig. 1 Human LDLR family members.1

VLDLR Protein Function: Roles in Reelin-Dab1 Signaling, Neuronal Migration, and Lipoprotein Metabolism

VLDLR, encoded by the VLDLR gene, functions as a multifunctional type I transmembrane receptor with dual roles in signaling and endocytosis:

  • Reelin-Dab1 Signaling: VLDLR binds Reelin via its first LA repeat in a calcium-dependent manner, inducing receptor clustering and tyrosine phosphorylation of the intracellular adaptor Dab1, which recruits downstream SH2 domain-containing proteins including Crk, Nckβ, and PI3K.
  • Neuronal Migration Regulation: Through Reelin-Dab1 signaling, VLDLR controls neuronal positioning during brain development, and loss of VLDLR function leads to cerebellar hypoplasia and cortical malformations.
  • Lipoprotein Endocytosis: VLDLR binds and internalizes ApoE-containing lipoproteins including VLDL, contributing to tissue delivery of VLDL-triglyceride-derived fatty acids and lipid homeostasis.
  • Regulated Proteolytic Processing: VLDLR undergoes α-secretase- and γ-secretase-mediated cleavage, releasing soluble extracellular and intracellular domains that may modulate receptor activity and downstream signaling.
  • Clathrin-Mediated Internalization: The cytoplasmic NPXY motif mediates clustering of VLDLR into clathrin-coated pits, enabling receptor-mediated endocytosis of bound ligands.

VLDLR Membrane Protein Product

Creative Biolabs offers high-quality VLDLR membrane protein products produced using optimized expression systems. These include full-length type I transmembrane protein that retains the native membrane-spanning domain and cytoplasmic NPXY motif, as well as isolated extracellular domain variants containing the LA repeats and EGF-like domains. The LA repeats mediate ligand binding to Reelin and ApoE-containing lipoproteins, making these proteins suitable for studies of Reelin-VLDLR interactions, lipoprotein binding, and receptor-mediated signaling characterization. All VLDLR proteins undergo strict quality control to support consistent performance across applicable research platforms.

Custom VLDLR Protein Product

Not finding the protein product you need? Contact us to start your one-stop custom service!

VLDLR Stable Cell Line Product

Creative Biolabs provides custom-engineered VLDLR stable cell lines, including overexpression and knockdown models. These cell lines are optimized for studies of Reelin-Dab1 signaling, neuronal migration, lipoprotein endocytosis, and VLDLR-mediated signaling pathways. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.

VLDLR Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

VLDLR Recombinant Antibody Product

High-specificity recombinant antibodies targeting VLDLR are developed using antibody engineering technologies for research applications involving VLDLR expression and localization. These antibodies can be used in studies of VLDLR distribution in neuronal tissues and lipoprotein-metabolizing tissues and may also support characterization of VLDLR-containing signaling complexes in combination with appropriate detection reagents.

VLDLR Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • Native LDLR Family Structure Preservation: Maintains the characteristic LA repeat and EGF-like domain architecture essential for ligand binding and receptor-mediated endocytosis studies.
  • Neuronal Signaling Research Compatibility: Optimized reagent series for studies of Reelin-Dab1 signaling, neuronal migration, and synaptic plasticity.
  • High Specificity for VLDLR: Minimizes non-specific cross-reactivity with other LDLR family members including LDLR and ApoER2.
  • Comprehensive Customization Support: Facilitates end-to-end development of customized proteins, antibodies and stable cell lines to address lipoprotein receptor biology and neuronal signaling research demands.

Custom VLDLR Research Services

Beyond catalog products, Creative Biolabs offers specialized custom services for VLDLR research:

  • Custom VLDLR Protein Production: Tailored expression of mutant and tagged VLDLR constructs for ligand binding and signaling studies.
  • Custom Antibody Development: Generation of VLDLR-specific antibodies for immunostaining, flow cytometry, and protein detection applications.
  • Stable Cell Line Engineering: Construction of VLDLR-modified cell models for Reelin signaling, lipoprotein metabolism, and neuronal migration research.
  • Functional Assay Development: Custom design of ligand binding, Dab1 phosphorylation, and lipoprotein uptake detection workflows.

Frequently Asked Questions (FAQs)

  1. What is the primary function of VLDLR?

    VLDLR is a multifunctional type I transmembrane receptor that binds Reelin to activate Dab1-dependent signaling for neuronal migration, and also mediates endocytosis of ApoE-containing lipoproteins for lipid metabolism.

  2. Why is VLDLR a significant research target?

    VLDLR is a key receptor in the Reelin signaling pathway controlling brain development. Its loss-of-function mutations cause cerebellar hypoplasia and intellectual disability, and it also plays roles in lipoprotein metabolism, making it important for neurodevelopmental and metabolic research.

  3. Are Creative Biolabs' VLDLR products suitable for clinical use?

    No, all VLDLR products and services are strictly for research use only, not intended for clinical diagnosis or treatment.

  4. What types of VLDLR products does Creative Biolabs offer?

    Offerings include full-length VLDLR membrane proteins, extracellular domain variants, specific detection antibodies, and custom stable cell lines for Reelin signaling and lipoprotein metabolism research.

  5. How are VLDLR proteins validated for activity?

    VLDLR proteins are validated via ligand binding assays, Dab1 phosphorylation assays, and relevant functional characterization in applicable research platforms.

Reference
  1. Príncipe, Catarina, et al. "LRP1B: A Giant Lost in Cancer Translation." Pharmaceuticals, 14.9 (2021): 836. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ph14090836
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;